GlycoT was awarded a Phase II SBIR titled " Development of streamlined one-pot chemoenzymatic glycan remodeling systems for antibody conjugation" (1R44GM153003) with total funding support of $1.7 M.
Research and Development Collaborations
To request a quote for our products, customized service, investment opportunities, or if you have any general inquiry for our company click the start now button.
